Weekly TP-HDFL in the Treatment of Advanced TCC

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

December 31, 2004

Conditions
Transitional Cell Carcinoma
Interventions
DRUG

Paclitaxel, Cisplatin, 5-Fluorouracil

Trial Locations (1)

100

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00154687 - Weekly TP-HDFL in the Treatment of Advanced TCC | Biotech Hunter | Biotech Hunter